Just like the immense sins of Jack Welch and GE will always tarnish six Sigma it is past time to realize that the conservative, looking backwards to Toyota of much of Lean thinking is a mistake that limits adoption and more importantly innovation.
As a company there is much at Toyota that is just wrong. The 2020 recalls were significant, but frankly not the first year the company has been having major quality contorl issues.
But more important is the fact the company is a liar and a supporter of authoritarianism. As a promponent of the pillars of Lean thats just damn hypocritical. After the failed coup of Janaury 6th, Toyota pledged to no longer fund anyone who supported the attack against US democracy. As of June they are the top fundraiser to those Republicans, giving to nearly a quarter of the 147 GOP politicians who objected to certifying the election results.
Toyota is showing us who they are. A company that stands apart from the principles so important to the Quality profession.
For root cause analysis, read the University of Chicago study that found that America’s biggest police forces lack legality, as they are not answerable to human rights compliant laws authorizing the use of lethal force.
It is impossible not to reach the conclusions that the culture is rotten, there are inherently bad actors, and institutional resistance to change is standing in way of improvement.
Given the continued failures in implementing change, it is time to shift the resistors out of police departments. The only way to effectively do that seems to radically restructure the police, breaking their responsibilities up and sending those responsibilities to organizations better suited for these duties.
As we continue to have multiple biosimilar and potential interchangeable approvals for the same reference product, it is important to consider how product drift will impact biosimilar products approved at different times, as well as the characteristics of the biosimilar product itself.
Ha Kung Wong (2019). Will product drift cause a rift? PharmaManufacturing
Excellent article on biosimilars and product drift. The rush for biosimilars needs to always remember how biologics are extremely sensitive to changes in the manufacturing process. Biosimilars require the most robust of quality systems and I worry that companies attracted to them for their price savings might cut corners.
I firmly believe that quality and ethics go hand-in-hand, and frankly it shakes some of my confidence on my profession when I read of organizations that supposedly subscribe to quality principles and standards (such as the ISOs) still not meeting the grade.
There are four widely accepted principles in biomedicine, which applies equally to medical devices and pharmaceuticals:
Principle of respect for autonomy
Principle of nonmaleficence
Principle of beneficence
Principle of justice
It seems a failure of ISO 13458 that adherence to this quality standard does not lead to results aligned to these four principles. It should surprise no one who knows me that this is one of the reasons I support strong regulations in this space.
Beauchamp T, Childress J. Principles of Biomedical Ethics, 7th Edition. New York: Oxford University Press, 2013
There is a strong correlation between quality and ethics. Leadership’s demonstration of their philosophy and practice of ethical behavior impacts the whole organization in education, government or commercial enterprises
Quality is a management methodology, a set of ethics and a grab-bag of technical skills and tools (many of which are not unique to quality). Dennis Sergent does a good job riffing off of Deming’s Code of Professional Conduct, and in light of my recent post “Being a Quality Leader” I wanted to briefly talk about how leadership is perhaps the most effective lever in producing an ethical organization.